The Nelson Report

The appointment of P&C veteran Rick Becker isn't just a new hire; it's a strategic bet on embedding practical, production-ready AI into core insurance operations.

Amid market turbulence, Andrew Farkas is forging a new powerhouse. The NAI Global deal isn't just a shuffle; it's a key move in a plan to master the downturn.

European approval for Bavarian Nordic's pediatric mpox vaccine is a critical health breakthrough and a masterclass in strategic market positioning.

iRhythm's stellar Q2 results are just the start. A major acquisition and a new AI algorithm are set to reshape the cardiac monitoring landscape.

Colossal Foundation's rewilding fund offers cash and genetic tech to save seven species. But can a $250k budget tackle a $5M problem and prove its model?

A reported net loss obscures core growth at 10x Genomics. An acquisition, key partnerships, and a blockbuster product launch signal a decisive strategic pivot.

A Texas energy upstart is winning awards by ditching gimmicks for loyalty. BKV Energy's model reveals a major shift in what consumers want: honesty.

By signing the Open Weights Letter, RedCloud is betting its unique $6.9B dataset, not AI models, is the key to solving a $2T global inventory crisis.

Magnite's Q2 results show its CTV strategy is a powerful growth engine. The company beat estimates and raised its 2026 outlook, citing programmatic shifts.

A new survey reveals commercial EV charging has passed a tipping point. Businesses now see it as essential and are ditching the lowest-cost mindset.

Fintech lender Lower is betting millions on a 2% grant to help buyers overcome the down payment hurdle. Is this a sustainable market disruption or a new risk?

With a fortified balance sheet and a strategic pivot, OnKure Therapeutics is betting that precision and selectivity will conquer a competitive drug market.

Heritage brand Dionis is leveraging 40 years of expertise to enter the booming baby care market. We unpack the strategy behind this multi-channel, high-growth bet.

A new study reveals 72% of Americans are wary of AI's local impact, creating a major operational and social hurdle for the tech industry's expansion.

Grip Boost's new Big Skill 2.0 gloves, backed by All-Pro Quinn Meinerz, target football's most overlooked position with disruptive operational innovation.

For millions with back pain, diagnosis is a guess. Aclarion's AI platform promises a 97% success rate, and it's expanding with a key Indiana partnership.

A 22% AFFO surge and record RevPAR aren't luck. Inside Chatham Lodging's Q2 success driven by strategic buys and relentless operational efficiency.

Pathos AI leverages its Foundry platform to ink a $2.2B deal with Alphamab for a novel cancer drug, signaling a new era of AI-led pharma strategy.

GBDC posts a return to profitability and maintains its dividend, but a closer look reveals strategic capital moves amid subtle shifts in portfolio health.

An urban farm becomes a tech hub as the Mark Cuban Foundation partners with Bonton Farms to bring a free AI bootcamp to underserved Dallas teens.